Search For "central drugs standard"
Central Drugs Standard Control Organisation extends Covaxin shelf life to
Updated : 4 years, 9 months ago IST
New Delhi [India], November 3 (ANI): Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin has received an extension of shelf life for up to 12 months from the date of manufacturing on Wednesday by India's pharmaceuticals and medical regulatory body.
Read More
LumiraDx receives approval for its COVID-19 Antigen test for use in India
Updated : 4 years, 9 months ago IST
London [UK], October 20 (ANI/NewsVoir): Today, LumiraDx, a next-generation point of care diagnostics testing company announced it has received emergency use approval by India's Central Drugs Standard Control Organisation for its SARS-CoV-2 Antigen test for use in India.
Read More
COVID-19: J&J applies for approval to conduct clinical trials on adole
Updated : 4 years, 11 months ago IST
New Delhi [India], August 20 (ANI): US pharma giant Johnson & Johnson has moved an application before the Central Drugs Standard Control Organisation (CDSCO) in India, seeking permission to conduct clinical trials of its single-dose Janssen vaccine against COVID-19 on adolescents (chi
Read More
Expert panel recommends trials on mixing Covaxin and Covishield
Updated : 5 years ago IST
New Delhi [India], July 30 (ANI): The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) on Thursday recommended granting permission for trials of mixing COVID-19 vaccines--Covaxin and Covishield--said sources.
Read More
Zydus Cadila, first Indian Company gets recommendation for clinical trials
Updated : 5 years, 1 month ago IST
New Delhi [India], June 4 (ANI): The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 has been recommended to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drug
Read More
Lilly signs pact with Natco to accelerate availability of baricitinib for
Updated : 5 years, 2 months ago IST
New Delhi [India], May 17 (ANI): Eli Lilly and Company said on Monday it has issued an additional royalty-free, non-exclusive voluntary license to Natco Pharma, a local pharmaceutical manufacturer of generic medicines.
Read More
Lilly signs pacts with Cipla, Lupin, Sun Pharma to accelerate availability
Updated : 5 years, 2 months ago IST
New Delhi [India], May 10 (ANI): US pharmaceutical major Eli Lilly said on Monday it has issued royalty-free, non-exclusive voluntary licenses to Cipla, Lupin and Sun Pharmaceutical to accelerate and expand the availability of baricitinib in India for Covid-19 patients.
Read More
COVID-19: India to decide emergency use authorisation of Sputnik V vaccine
Updated : 5 years, 4 months ago IST
New Delhi [India], March 31 (ANI): Meeting of Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) will be held on Wednesday to deliberate on emergency use authorisation application of Russian vaccine Sputnik V.
Read More
SEC recommends Dr Reddy's to submit additional data for EUA of Sputnik V C
Updated : 5 years, 5 months ago IST
New Delhi [India], February 24 (ANI): The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) has recommended additional immunogenicity data from Dr Reddy's Laboratories which applied to the national drugs regulator seeking emergency use approval for Sputnik
Read More
SEC to discuss Dr Reddy's application for emergency use of Sputnik V vacci
Updated : 5 years, 5 months ago IST
New Delhi [India], February 24 (ANI): The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) is going to meet on Wednesday afternoon to discuss Dr Reddy's Laboratories application seeking emergency use approval (EUA) for SputnikV, a Russian Vaccine.
Read More
DCGI to brief media today on COVID-19 vaccine
Updated : 5 years, 7 months ago IST
New Delhi [India], January 3 (ANI): The Drugs Controller General of India will brief the media at 11 am today at the National Media Centre regarding the coronavirus vaccine.
Read More
COVID-19: Expert committee recommends restricted emergency use of SII, Bha
Updated : 5 years, 7 months ago IST
New Delhi [India], January 2 (ANI): The Subject Expert Committee (SEC) of Central Drugs Standards Control Organisation on Saturday made recommendations to the Drugs Controller General of India to grant permission for restricted emergency use of SII, Bharat Biotech's vaccines.
Read More